Scientific Board:
T. Poskus, MD, PhD
N.E. Samalavicius, MD, PhD
RECENT ADVANCES IN THE MANAGEMENT OF COLORECTAL CANCER
Novotel Vilnius,
May 6–7, 2005
Vilnius, Lithuania
Course Directors: S. Iacobelli, N. E. Samalavicius, T. Poskus
Welcome
Dear Colleagues,
We are honoured to invite you to attend this course on „Recent advances in the management of colorectal cancer” which is organized by the Mediterranean School of Oncology and European School of Oncology in collaboration with Lithuanian Society of Coloproctologists and Oncology Institute of Vilnius University.
The course will provide an ideal opportunity for the participants to update in a comprehensive manner their knowledge on the different aspects of colorectal cancer, including epidemiology, genetics, screening, prevention, surgery, chemotherapy and radiotherapy.
We certainly hope that you will appreciate the educational program of the course, including discovering spring in a remarkable old Vilnius full of beautiful spots, history and hospitality.
Narimantas Evaldas Samalavicius, MD, PhD
President of the Lithuanian Society of Coloproctology
Course description
Colorectal cancer remains one of the most challenging problems worldwide. Even in Lithuania, in the last years colorectal cancer incidence has been increasing from 4 to 6 percent each year, with up to one and a half thousand new cases per year in a population of 3,5 million inhabitants. However, occupying a very important role in the whole burden in the reasons of death from malignant diseases, colorectal cancer today may be cured, specially at an early stage, and in some instances prevented. Thus this course aims to give an update in prevention, diagnosis and treatment of this disease. Progress in genetics and pathology dramatically increased our knowledge in the spheres which not so long ago lay dormant, and enables clinicians not only to deal with these conditions or premalignant lesions, but leaves them with duty of indentifying potential risks groups and taking measures known to be effective for preventing colorectal cancer.
The program focuses on clinical, genetic and pathological correlations with an emphasis on screening, prevention, diagnosis, surgical and medical treatment modalities of colorectal cancer today. Contributors of this course will give state of art lectures in the most important topics.
The program is intended for the residents in gastroenterology and surgery, colorectal surgeons, general surgeons and gastroenterologists, medical oncologists, family doctors, pathologists, geneticists and all those health care professionals who are involved in the management of colorectal cancer. Participants are as well expected not only from Lithuania, but from neghbouring countries, including Latvia, Estonia, Russia, Poland, Belorussia and Ukraine.
We do hope that course participants will remember this course of the Mediterranean School of Oncology and European School of Oncology as a highlight of up-to-date training in the field of colorectal cancer.
Program
Thursday May 5
- 14.00–18.00 Registration
- 20.00 Welcoming reception and dinner
Friday May 6
INTRODUCTION
- 14.00–14.05 Mediterranean School of Oncology/European School of Oncology colorectal cancer course in Vilnius
(N. E. Samalavicius, Vilnius, Lithuania) - 14.05–14.15 Colorectal cancer course and Mediterranean School of Oncology
(S. Iacobelli, Chieti, Italy)
EPIDEMIOLOGY AND PREVENTION I
- 14.15–15.00 Epidemiology of colorectal cancer: what can we learn from Lithuania?
(J. Kurtinaitis, Vilnius, Lithuania) - 15.00–15.45 Chemoprevention
(A. Decensi, Genova, Italy) - 15.45–16.45 Screening of colorectal cancer
(P. Rozen, Tel Aviv, Israel)
COFFEE BREAK 16.45–17.15
- 17.15–18.00 Genetics of colorectal cancer, familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer
(A. Alonso, Pamplona, Spain) - 18.00–18.45 Screening, treatment and follow-up of familial colorectal cancer
(N. E. Samalavicius, Vilnius, Lithuania)
Saturday May 7
EPIDEMIOLOGY AND PREVENTION II
- 8.30–9.15 Premalignant lesions (polyps) of the colon
(T. Poskus, Vilnius, Lithuania) - 9.15–9.45 Inflammatory bowel disease and colorectal cancer
(G. Olaison, Linkoping, Sweden)
SURGERY & RADIATION THERAPY
- 9.30–10.15 The issue of radicality and future trends in colon cancer surgery
(A. Balogh, Szeged, Hungary)
COFFEE BREAK 10.15–10.45
- 10.45–11.30 Surgery for rectal cancer
(P. Innocenti, Chieti, Italy) - 11.30–12.30 Radiotherapy for rectal cancer today
(O. Thomas, Nice, France)
LUNCH 12.30–13.30
- 13.30–14.15 Surgery of liver metastasis from colorectal cancer
(J. Pundzius, Kaunas, Lithuania)
MEDICAL THERAPY AND NEWER THERAPEUTIC APPROACHES
- 14.15–15.15 Chemotherapy, biological therapy and cancer vaccines
(S. Iacobelli, Chieti, Italy) - 15.15–16.00 Conservative treatment of liver metastasis
(A. Cesas, Klaipeda, Lithuania) - 16.00–16.10 Closing remarks
(S. Iacobelli / N.E. Samalavicius)
Faculty
Adam Balogh
Department of Surgery
University of Szeged
Szeged, Hungary
Alvydas Cesas
Medical oncologist
Klaipeda City Hospital
Klaipeda, Lithuania
Andrea Decensi
E. O. Ospedali Galliera
Genova, Italy
Stefano Iacobelli
Department of Medical Oncology
University „G. D’Annunzio”
Chieti, Italy
Paolo Innocenti
Department of Surgery
University „G. D’Annunzio”
Chieti, Italy
Juozas Kurtinaitis
The Lithuanian Cancer Registry
Oncology Institute of Vilnius University
Vilnius, Lithuania
Gunnar Olaison
Colorectal Surgery Unit
Department of Surgery
University Hospital
Linköping, Sweden
Tomas Poskus
Colorectal Unit III Department of Surgery
Vilnius University Hospital Santariskiu Klinikos
Center branch
Vilnius, Lithuania
Juozas Pundzius
Clinic of Surgery
Kaunas University of Medicine
Kaunas, Lithuania
Paul Rozen
Department of Gastroenterology
Tel Aviv Medical Centre
Tel Aviv, Israel
Narimantas Evaldas Samalavicius
Colorectal Unit III Department of Surgery
Vilnius University Hospital Santariskiu Klinikos
Center branch
Vilnius, Lithuania
Angel Alonso Sanchez
Department of Genetics
Hospital Virgen del Camino
Pamplona-Iruna, Spain
Olivier Thomas
Department of Radiotherapy
Centre Antoine-Lacassagne
Nice, France
Recommended accommodation
NOVOTEL VILNIUS
Gedimino pr. 16
LT-01103 Vilnius, Lietuva
Tel.: +370 5 266 62 00
Fax: +370 5 266 62 01
E-mail: H5209@accor-hotels.com
www.novotel.com
www.accorhotels.com
COMFORT VILNIUS
Geliu Str. 5
LT-01137 Vilnius
Lithuania
Tel: +370 5 2648838
Fax: +370 5 2648832
E-mail: rimantas@comfort.lt
www.comfort.lt
Registration
Registration fee: 50 Euro. This includes participation in the classes, educational material, working lunches, coffee breaks and course dinner on Thursday, May 5.
Social events: To be announced later
Payment
By Bank Transfer only. Ask your bank to send a wire transfer (SWIFT method) for the sum of 50 Euro to:
Bank name: Cassa di Risparmio della Provincia di Chieti
66100 Chieti, Italy
Account name: CINBO-MSO
Account number: 90051
ABI Code (Bank Code): 06050
CAB Code (Agency or Branch Code): 15598
CIN CODE: V
IBAN: IT 48V0605015598CC0990090051
Reason for transfer of funds: „Fee for [your name], course [course name]”
A copy of the Registration Form together with the receipt of payment must be sent by fax (+39 0871 3556707) or by regular mail to the Secretariat.
Cancellation and refund
Cancellations should be notified in writing to the Organizing Secretariat (email or fax). Cancellations received 15 days before beginning of the course: 30% refund; cancellations received after 15 days before the beginning of the course: no refund.
Accreditation
The course program is submitted for accreditation to ESO Educational Committee for CME credits. Upon completion of the course, participants will receive a certificate of attendance including an indication of the number of the credits awarded.
Language
The course will be conducted in English; therefore a good command of the English language is indespensible.
Further information
Tomas Poskus, MD
E-mail: toshcus@yahoo.com
Phone: +370 686 78893
Fax: +370 52 614625
Mediterranean School of Oncology
Director: Stefano Iacobelli, M.D.
Organizing Committee and Advisory Board:
Angelo Raffaele Bianco, M.D.
Ermelando V. Cosmi, M.D.
Guidalberto Fabris, M.D.
Nicola Gebbia, M.D.
Francesco Grignani, M.D.
Italo Nenci, M.D.
Salvatore Venuta, M.D.
Michele De Tursi, M.D.
Nicola Tinari, M.D.
Scientific Advisor:
Michele De Tursi, M.D.
Nicola Tinari, M.D.
Organizing Secretariat:
Mrs. Giovanna Di Credico
Mrs. Anna Scattone
Administration:
Mrs. Cristina Salvatore
Mediterranean School of Oncology
c/o Cattedra di Oncologia Medica
Università G. D’Annunzio
Via dei Vestini, 5
66100 Chieti, Italy
Tel: +39 0871 355 6732
Fax: +39 0871 355 6707
E-mail: mso.cinbo@unich.it
Course Coordination:
Mrs. Valeria Cannavicci
Email: mso.org@tiscali.it
Mobile: +39 347 2200978
Internet: http://www.unich.it/mso.cinbo